|

Darolutamide (BAY1841788) + docetaxel + ADT Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Bayer1

Indications

  • Low-volume Metastasis1
  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)1
  • Cancer1

Other1 trial

A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.